Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?

详细信息    查看全文

• 作者：Myrthe M. van Dijk ; MD^a ; ^{m.m.vandijk@amc.uva.nl" class="auth_mail" title="E-mail the corresponding author} ; Nehalennia van Hanegem ; MD^a ; ^b ; Maria E. de Lange^a ; Anne Timmermans ; MD ; PhD^a
• 关键词：Endometrial polyp ; Heavy menstrual bleeding ; Hysteroscopic polypectomy ; Levonorgestrel-releasing intrauterine device
• 刊名：Journal of Minimally Invasive Gynecology
• 出版年：2015
• 出版时间：November-December 2015
• 年：2015
• 卷：22
• 期：7
• 页码：1153-1162
• 全文大小：750 K

文摘

We performed a literature review of reports comparing a levonorgestrel-releasing intrauterine device (LNG-IUD) with transcervical polyp resection (TCRP) as a treatment for heavy menstrual bleeding (HMB). Our second objective was to investigate the effectiveness of LNG-IUD and TCRP in reducing menstrual bleeding and the patient satisfaction with each technique. No previously reported studies have compared TCRP and LNG-IUD as treatment for HMB in premenopausal women with an endometrial polyp. Likewise, no studies are available on LNG-IUD as a treatment for HMB in the presence of an endometrial polyp. Several studies have found the LNG-IUD to be an effective treatment option for HMB, with high patient satisfaction rates. Evidence of the effectiveness of TCRP as treatment of HMB is scarce. Patient satisfaction is reported relatively good, although persistent or recurrent symptoms appear to be frequent. We conclude that no evidence is available on LNG-IUD as treatment for HMB in women with an endometrial polyp. We hypothesize that LNG-IUD could be a good alternative to TCRP for treating HMB in premenopausal women with a polyp; however, further evidence is needed, and a randomized controlled trial should be performed.